CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

The CEO of UnitedHealth Group said Thursday that shortcomings of America’s health care system must be addressed.

The report notes that large employers' perceptions about PBM performance have not changed much over the past 5 years. Employers continue to be more satisfied with core PBM services and ...

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on UnitedHealth (UNH – Research Report). The associated price target ...

Validation Institute, the definitive organization for independently validating the health outcomes and savings claims of healthcare solution providers, announced a new innovation aimed at saving time ...

Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...

Operator Good morning and welcome to the UnitedHealth Group fourth quarter and full year 2024 earnings conference call. A ...

We came across a bullish thesis on The Cigna Group (CI) on Twitter by Tsachy Mishal. In this article, we will summarize the ...

UnitedHealth’s net income plummeted to its lowest level since 2019 amid hefty costs, including some from the Change ...

Analyst Richard Close of Canaccord Genuity maintained a Buy rating on Evolent Health (EVH – Research Report), retaining the price target of ...

Sarah James; Analyst; Cantor Fitzgerald Joanna Gajuk; Analyst; BofA Global Research ...

Biden spent like no president in history, and, with a sleight of hand, by taking hundreds of billions out of Medicare and ...